IL248327A0 - Human variable lymphocyte receptors and related compositions and uses - Google Patents

Human variable lymphocyte receptors and related compositions and uses

Info

Publication number
IL248327A0
IL248327A0 IL248327A IL24832716A IL248327A0 IL 248327 A0 IL248327 A0 IL 248327A0 IL 248327 A IL248327 A IL 248327A IL 24832716 A IL24832716 A IL 24832716A IL 248327 A0 IL248327 A0 IL 248327A0
Authority
IL
Israel
Prior art keywords
vlr
compositions
humanized variable
uses related
lymphocyte receptors
Prior art date
Application number
IL248327A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of IL248327A0 publication Critical patent/IL248327A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL248327A 2014-05-02 2016-10-13 Human variable lymphocyte receptors and related compositions and uses IL248327A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461987566P 2014-05-02 2014-05-02
PCT/US2015/028645 WO2015168469A1 (en) 2014-05-02 2015-04-30 Humanized variable lymphocyte receptors (vlr) and compositions and uses related thereto

Publications (1)

Publication Number Publication Date
IL248327A0 true IL248327A0 (en) 2016-11-30

Family

ID=54359347

Family Applications (1)

Application Number Title Priority Date Filing Date
IL248327A IL248327A0 (en) 2014-05-02 2016-10-13 Human variable lymphocyte receptors and related compositions and uses

Country Status (8)

Country Link
US (3) US10167330B2 (enExample)
EP (1) EP3137496A4 (enExample)
JP (1) JP2017514522A (enExample)
KR (1) KR20160147787A (enExample)
CN (1) CN106459173A (enExample)
CA (1) CA2947429A1 (enExample)
IL (1) IL248327A0 (enExample)
WO (1) WO2015168469A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160147787A (ko) 2014-05-02 2016-12-23 에모리 유니버시티 인간화 가변 림프구 수용체（ｖｌｒ） 및 이와 관련된 조성물 및 용도
SE1500434A1 (en) * 2015-10-29 2017-04-30 Theravac Pharmaceuticals Ab A novel fusion partner for highly efficient and safe vaccines
US11339225B2 (en) * 2016-05-12 2022-05-24 Asclepius (Suzhou) Technology Company Group, Co., Ltd. Bispecific antigen-binding construct and preparation method and use thereof
CN107365387B (zh) 2016-05-12 2022-03-15 阿思科力(苏州)生物科技有限公司 一种双特异性抗原结合构建体及其制备方法和应用
CN106543278B (zh) * 2016-12-06 2019-04-12 阿思科力(苏州)生物科技有限公司 融合蛋白Slit2D2(C386S)-HSA及其在治疗纤维化疾病中的应用
EP3573665A4 (en) * 2017-01-27 2020-11-11 Board Of Supervisors Of Louisiana State University BIFUNCTIONAL SMALL PEPTIDE FOR AUTOIMMUN DIABETES
BR112019019973A2 (pt) * 2017-03-24 2020-04-28 Orpheus Bioscience Inc pantlds para tratamento de transtornos autoimunes
MX2019012198A (es) * 2017-04-11 2020-01-21 Inhibrx Inc Constructos de polipéptidos multiespecíficos que tienen unión limitada a cd3 y métodos de utilización de los mismos.
KR101972894B1 (ko) * 2017-05-18 2019-04-29 경상대학교산학협력단 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 칠성장어 유래 vlrb 단백질의 c 말단 서열이 연결된 융합 단백질 및 이의 용도
US20190330366A1 (en) 2018-04-11 2019-10-31 Inhibrx, Inc. Multispecific polypeptide constructs having constrained cd3 binding and related methods and uses
EP3827019A1 (en) 2018-07-24 2021-06-02 Inhibrx, Inc. Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the same
JP7611820B2 (ja) 2018-10-11 2025-01-10 インヒブルクス バイオサイエンシズ インコーポレイテッド Ｄｌｌ３シングルドメイン抗体およびその治療用組成物
WO2020132301A1 (en) * 2018-12-21 2020-06-25 Wisconsin Alumni Research Foundation Variable lymphocyte receptors that target the brain extracellular matrix and methods of use
WO2020167735A1 (en) 2019-02-11 2020-08-20 Wisconsin Alumni Research Foundation Variable lymphocyte receptors that target the blood brain barrier and methods of use
EP4377338A2 (en) 2021-07-27 2024-06-05 Novab, Inc. Engineered vlrb antibodies with immune effector functions
CN114891799B (zh) * 2022-05-20 2024-10-11 宁波大学 中华绒螯蟹可变淋巴受体vlr2基因及其编码的蛋白和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1118777A (ja) * 1997-07-09 1999-01-26 Asahi Chem Ind Co Ltd 新規スリット様ポリペプチド
US8039588B2 (en) * 2004-05-21 2011-10-18 The Uab Research Foundation Variable lymphocyte receptors
NZ574473A (en) 2006-08-02 2013-02-22 Uab Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
WO2010065407A2 (en) 2008-12-01 2010-06-10 University Of Maryland Biotechnology Institute High affinity recombinant sea lamprey antibodies selected by a yeast surface display platform
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
CN104066751A (zh) 2011-11-22 2014-09-24 马里兰州大学(巴尔的摩) 对聚糖具有高亲和力和选择性的lambody及其用途
CN103033617B (zh) * 2012-11-30 2014-12-03 辽宁师范大学 基于可变淋巴细胞受体的肿瘤标志物检测试剂盒及其制备方法
TWI654206B (zh) 2013-03-16 2019-03-21 諾華公司 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症
KR20160147787A (ko) 2014-05-02 2016-12-23 에모리 유니버시티 인간화 가변 림프구 수용체（ｖｌｒ） 및 이와 관련된 조성물 및 용도

Also Published As

Publication number Publication date
WO2015168469A1 (en) 2015-11-05
US20170081385A1 (en) 2017-03-23
EP3137496A1 (en) 2017-03-08
US11384134B2 (en) 2022-07-12
CN106459173A (zh) 2017-02-22
US20200308247A1 (en) 2020-10-01
EP3137496A4 (en) 2017-10-11
KR20160147787A (ko) 2016-12-23
JP2017514522A (ja) 2017-06-08
CA2947429A1 (en) 2015-11-05
US10167330B2 (en) 2019-01-01
US20190202887A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
IL248327A0 (en) Human variable lymphocyte receptors and related compositions and uses
HRP20210342T8 (hr) Pripravci glikopeptida
IL256295A (en) Anti-ntb-a antibodies and related compositions and methods
PT3674315T (pt) Recetores de antigénios quiméricos, composições e métodos
PL3151672T3 (pl) Ulepszone kompozycje limfocytów t
IL251282A0 (en) Preparations containing anti-il-7r antibody
SG11201609059TA (en) Fuel compositions
GB2528306B (en) Sliding engine component
GB201717974D0 (en) Modified receptors
IL252161A0 (en) Stabilized ophthalmic preparations that include omega-3
IL246879B (en) Preparations of Epilimod and methods of using them
SG11201606035RA (en) Fuel compositions
ZA201800822B (en) Fuel compositions
GB2522035B (en) Sliding engine component
GB201408167D0 (en) Compositions
IL251479A0 (en) components
IL249695A0 (en) Converted polymyxins and preparations containing them
GB201404764D0 (en) Sliding engine component
GB201420306D0 (en) Compositions
GB201405657D0 (en) Additive carrying composition
SI3191080T1 (sl) Parenteralni sestavki in njihova uporaba
GB201501069D0 (en) NK power-wind turbine
GB201419849D0 (en) Compositions
GB201406863D0 (en) Compositions comprising variegin
GB201401825D0 (en) Fuel compositions